ALXN - Alexion Pharmaceuticals Inc. (ALXN) CEO Ludwig Hantson on Q2 2019 Results - Earnings Call Transcript
Alexion Pharmaceuticals, Inc. (ALXN)
Q2 2019 Earnings Conference Call
July 24, 2019 08:00 AM ET
Company Participants
Susan Altschuller - Vice President of Investor Relations
Ludwig Hantson - Chief Executive Officer
Paul Clancy - EVP and Chief Financial Officer
John Orloff - EVP, Head of Research and Development
Brian Goff - EVP, Chief Commercial Officer
Conference Call Participants
Geoffrey Porges - SVB Leerink
Matthew Harrison - Morgan Stanley
Chris Raymond - Piper Jaffray
Martin Auster - Credit Suisse
Phil Nadeau - Cowen and Company
Nate Tower - Stifel
Kennen MacKay - RBC Capital Markets
Mohit